AIM
ANIP icon

Aigen Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Aigen Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,266
Closed -$206K – 1030
2021
Q3 		$206K Sell
6,266
-471
-7% -$14.6K 0.04% 417
2021
Q2 		$236K Sell
6,737
-1,224
-15% -$41.6K 0.04% 370
2021
Q1 		$288K Sell
7,961
-1,004
-11% -$31.4K 0.04% 427
2020
Q4 		$260K Buy
8,965
+290
+3% +$8.3K 0.03% 590
2020
Q3 		$245K Sell
8,675
-3,604
-29% -$107K 0.03% 590
2020
Q2 		$397K Buy
+12,279
New +$440K 0.05% 532

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return